We validated key proteomic findings, observing consistent up- and downregulation patterns across DLB subgroups for APP, UBB, EGFR, CLU, and PSMB10 through Western blot analysis with accompanying images and quantification. The gene discussed is CLU; the disease is Lewy body dementia.